Daniel Nieto Pujadas

Daniel Nieto Pujadas has a diverse range of work experience in the field of biomedical research. In 2023, they joined Minoryx Therapeutics as a Clinical Operations Trainee. Prior to that, in 2022, they completed a six-month Research Internship at Leiden University Medical Center, where they focused on research into Hereditary Hemorrhagic Telangiectasia (HHT) under the guidance of Dr. Franck Lebrin. In 2021, they also spent one month at the Bellvitge Biomedical Research Institute - IDIBELL, working as a Researcher in the Molecular Signaling in Cancer group led by Prof. Francesc Viñals.

Daniel Nieto Pujadas has a strong educational background in the field of biomedical sciences and pharmaceutical industry and biotechnology. In 2018, they began their undergraduate studies at Universitat de Barcelona, where they pursued a Bachelor's degree in Biomedical Sciences, General. Daniel successfully completed this program in 2022.

During their undergraduate studies, in 2018, Daniel also obtained a certification as a Leisure Monitor from Fundacio Pere Tarres. This certification demonstrates their interest and expertise in recreational activities and management.

In 2022, Daniel pursued an internship at Leiden University, focusing on clinical/medical laboratory science/research and allied professions. This opportunity allowed him to further expand their practical skills and knowledge in the field.

Following their internship, Daniel enrolled in the Universitat Pompeu Fabra in 2022 to pursue a Master's degree in Pharmaceutical Industry and Biotechnology, specializing in Pharmacology. This program is expected to be completed in 2023.

Overall, Daniel Nieto Pujadas has progressively built their educational foundation in biomedical sciences and is currently augmenting it with specialized knowledge in the pharmaceutical industry and biotechnology.